xanthenes has been researched along with Aura in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, H; Chen, Y; He, Q; Jiang, Y; Wu, X; Yuan, L | 1 |
| Bolwig, TG; Ernfors, P; Husum, H; Kokaia, M; Nanobashvili, A; Sørensen, AT; Sørensen, G; Woldbye, DP | 1 |
| Carlen, PL; Frantseva, MV; Hwang, PA; Velazquez, JL | 1 |
| Diehl, LW | 1 |
| Heinze, H | 1 |
5 other study(ies) available for xanthenes and Aura
| Article | Year |
|---|---|
[Effect of intracellular-free Ca2+ concentration on transient magnesium-free treatment induced epileptic injury in developing cortical neurons of rats].
Topics: Aniline Compounds; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Culture Media; Dizocilpine Maleate; Epilepsy; Magnesium; Neurons; Rats; Receptors, N-Methyl-D-Aspartate; Xanthenes | 2003 |
Differential suppression of seizures via Y2 and Y5 neuropeptide Y receptors.
Topics: Animals; Cells, Cultured; Convulsants; Cyclohexanes; Disease Models, Animal; Epilepsy; Epilepsy, Temporal Lobe; Excitatory Amino Acid Agonists; Female; Gene Expression Regulation; Genetic Predisposition to Disease; Hippocampus; Kainic Acid; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Neurons; Neuropeptide Y; Organ Culture Techniques; Receptors, Neuropeptide Y; Synaptic Transmission; Xanthenes | 2005 |
Free radical production correlates with cell death in an in vitro model of epilepsy.
Topics: Action Potentials; Aniline Compounds; Animals; Antioxidants; Bicuculline; Calcium; Cell Death; Disease Models, Animal; Epilepsy; Fluorescent Dyes; Free Radicals; GABA Antagonists; Glutathione; Hippocampus; Microscopy, Fluorescence; Nerve Degeneration; Organ Culture Techniques; Patch-Clamp Techniques; Pyramidal Cells; Rats; Rats, Wistar; Rhodamines; Vitamin E; Xanthenes | 2000 |
[Severe adverse effects of ciatyl in antiepileptic long-term therapy].
Topics: Adult; Clopenthixol; Drug Eruptions; Epilepsy; Female; Humans; Leukopenia; Middle Aged; Mouth Diseases; Piperazines; Salivation; Time Factors; Tranquilizing Agents; Xanthenes | 1972 |
[Clinical juvenile psychiatry experience with Ciatyl].
Topics: Adolescent; Anticonvulsants; Child; Child Behavior Disorders; Epilepsy; Humans; Piperazines; Psychopharmacology; Schizophrenia, Childhood; Xanthenes | 1967 |